Solid Tumor, Adult
2 competing products in clinical development for Solid Tumor, Adult.
Pipeline by Phase
Phase 11
Phase 1/21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eFT226 + Sotorasib + Fulvestrant + Abemaciclib + Trastuzumab | eFFECTOR Therapeutics | Phase 1/2 | Recruiting | 33 |
| BBP-398 + sotorasib | BridgeBio Pharma | Phase 1 | Terminated | 30 |